PDA

View Full Version : PharmaMar to present data on anticancer candidates PM1183 and plitidepsin at the AACR

News
04-17-2015, 01:13 AM
American Association for Cancer Research Annual Meeting April 18-22, 2015 Combination of the anticancer drug PM1183 with PARP inhibitors and doxorubicin results in a synergistic effect...

More... (http://www.medicalnewstoday.com/releases/292416.php)